Annual Drug Patent Expirations for MYDCOMBI
Mydcombi is a drug marketed by Eyenovia and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has forty-four patent family members in fourteen countries.
The generic ingredient in MYDCOMBI is phenylephrine hydrochloride; tropicamide. One supplier is listed for this compound. Additional details are available on the phenylephrine hydrochloride; tropicamide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
